Get 40% Off
⚠ Earnings Alert! Which stocks are poised to surge?
See the stocks on our ProPicks radar. These strategies gained 19.7% year-to-date.
Unlock full list

Egyptian International Pharma (PHAR)

Egypt
Currency in EGP
Disclaimer
44.98
-1.77(-3.79%)
Closed
PHAR Scorecard
High dividend Yield
Fair Value
Unlock Value
Day's Range
44.2047.00
52 wk Range
24.5053.49
Bid/Ask
44.60 / 46.00
Prev. Close
46.75
Open
46.75
Day's Range
44.2-47
52 wk Range
24.5-53.49
Volume
740,427
Average Volume (3m)
852,290
1-Year Change
73.94%
Shares Outstanding
148,755,750
Fair Value
Unlock
Dividends Payment Streak
Unlock
Analysts
Technical
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell

People Also Watch

35.00
SWDY
-5.79%
64.00
SUGR
-6.79%
31.75
SKPC
-9.03%
65.05
TMGH
-5.13%
How do you feel today about PHAR?
Vote to see community's results!
or

Egyptian International Pharma Company Profile

Egyptian International Pharmaceutical Industries Company manufactures and distributes medicines, and medical and veterinary preparations in Egypt and internationally. It produces various dosage forms, such as spansule capsules, soft gelatin capsules, lyophilized products, gels, sprayers, and effervescent tablets, as well as antibiotics. The company also provides Covid-19 related protocol medicine, including epicehin, epizithro, cetal, dexamethasone, and cevitil. gyptian International Pharmaceutical Industries Company was incorporated in 1980 and is based in 10th of Ramadan City, Egypt.

Employees
0
Market
Egypt
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.